Please check your internet connection and try again.
# Montelukast/Levocetirizine
## Overview
Montelukast is a leukotriene receptor antagonist. Levocetirizine is a second-generation H1 antihistamine. This combination is used for the management of allergic rhinitis and chronic urticaria.
## Primary Indications
* Allergic Rhinitis (seasonal and perennial)
* Chronic Idiopathic Urticaria
## Adult Dosing
* **Allergic Rhinitis/Chronic Urticaria:** One tablet (montelukast 10 mg/levocetirizine 5 mg) once daily.
## Pediatric Dosing
Dosing varies by product formulation and patient age/weight. Refer to specific product labeling.
* **Montelukast (component):**
* Children 6 to 14 years: 5 mg chewable tablet once daily.
* Children 2 to 5 years: 4 mg chewable tablet once daily.
* Children 6 months to 2 years: 4 mg oral granules once daily.
* **Levocetirizine (component):**
* Children 6 to 11 years: 5 mg oral solution or 5 mg chewable tablet once daily.
* Children 6 months to 5 years: 1.25 mg oral solution once daily.
## Dose Adjustments
* **Hepatic Impairment:** Caution advised. No specific dose adjustment for the combination product. Refer to individual component guidelines.
* **Renal Impairment:** No specific dose adjustment for the combination product. Refer to individual component guidelines for montelukast and levocetirizine. Levocetirizine may require dose adjustment in severe renal impairment.
## Contraindications
* Hypersensitivity to montelukast, levocetirizine, or any component of the product.
* Severe hepatic impairment (for montelukast component).
## Adverse Effects
* **Common:** Somnolence, fatigue, pharyngitis, cough, upper respiratory tract infection, diarrhea, abdominal pain, dizziness, headache, dry mouth, nausea, vomiting.
* **Neuropsychiatric:** Behavioral and sleep disturbances (including dreams, hallucinations, suicidal ideation, agitation, anxiety, insomnia, depression) have been reported with montelukast. Levocetirizine can cause somnolence.
## Key Drug Interactions
* **Theophylline:** Montelukast may increase theophylline serum concentrations. Monitor theophylline levels closely.
* **CNS Depressants (e.g., sedatives, hypnotics, benzodiazepines, opioids, alcohol):** Concomitant use with levocetirizine may increase the risk of sedation and CNS depression.
* **CYP1A2 Inhibitors (e.g., fluvoxamine, ciprofloxacin):** May increase montelukast exposure.
## Monitoring
* Monitor for efficacy in controlling allergic rhinitis or urticaria symptoms.
* Monitor for neuropsychiatric adverse events, especially with montelukast. Advise patients/caregivers to report any changes in behavior or mood.
* Monitor theophylline levels if co-administered with montelukast.
## Clinical Pearls
* This combination offers a dual mechanism for allergic conditions.
* Montelukast has a boxed warning for neuropsychiatric effects. Discuss potential risks with patients.
* Levocetirizine can cause significant sedation; advise avoidance of activities requiring mental alertness if somnolence occurs.
* Administer montelukast in the evening, especially if somnolence or other CNS effects occur.
***
This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant guidelines before making clinical decisions.
